Krótki terminŚredni terminDługi terminSygnały

Nurix Therapeutics Inc [NRIX]

Giełda: NASDAQ
Sektor: Healthcare
Branża: Biotechnology
Ostatnia aktualizacja 12 Jun 2026 @ 16:00 (Exchange is closed for the weekend)
Ostatnia: $16.95 -0.18%
0.82 (↑)
GaG Algo Score™
v1.0
Krótki
0.82 (↑)
Średni
2.50 (↑)
Długi
2.08
KUP
71.43%
zwrot 44.31%
SPRZEDAJ
32.00%
zwrot 46.81%

Statystyki

Dzisiejszy wolumen 2.56M
Średni wolumen 1.68M
Kapitalizacja 1.47B
EPS $-0.790 (Q1 | 2026-04-08)
Następna data wyników ($-0.730) 2026-07-09
P/E -5.35 (Sektor) 26.21 (Branża) 17.28
ATR14 $1.256 (7.41%)
Możliwy ruch dzienny $16.32 - $17.58 (7.70%)

Poziomy wsparcia i oporu

Linia

Dane pivot

Statystyki pivot
Metryka Średnia Mediana Odch. std.
Zysk % 26.45% 18.94% 23.53%
Strata % -13.21% -12.96% 4.79%
Czas trwania 16.5d 16d 8.5d
Łącznie znalezionych pivotów 16
Odcinki zysk/strata 15 (8 Zysk / 7 Strata)
Ostatni pivot Top @ $17.76 dnia 2026-05-29
Zmiana od ostatniego pivotu $-0.81 (-4.56%)
Prognoza następnego pivotu Ostatnia: $16.95
Przewidywany następny typ Bottom
Prognozowana cena (średnia) $15.41
Prognozowana cena (mediana) $15.46
Prognozowany zakres ceny (~68%) $14.56 - $16.26
Zmiana do średniego celu $-1.54 (-9.06%)
Prognozowana data (średnia) 2026-06-14
Prognozowany zakres dat (~68%) 2026-06-06 - 2026-06-23
Podstawa Based on 7 historical losses (Avg: -13.21%, Median: -12.96%, StdDev of Abs: 4.79%) and duration (Avg: 16.5 days, StdDev: 8.5 days)
Uwaga Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Nurix Therapeutics Inc edges lower, down -0.18%.

Nurix Therapeutics Inc (NRIX) stock price showed a minimal loss on Friday after the stock fell $-0.0300 (-0.18%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 0.31% rise. Yesterday's trading volume was 2.56M shares, worth about $43.44M. This represents 1.47M shares less than the day before. Volume was below the 10-day average of 4.19M shares.

Nurix Therapeutics Inc signals

There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Nurix Therapeutics Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $17.00. approximately $0.0500 (0.29%) away. Consolidating near resistance. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -

Nurix Therapeutics Inc Evaluation

  • Krótki wynik: 0.82
  • Średni wynik: 2.50
  • Długi wynik: 2.08